Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 085421
Company: PHARMERAL
Company: PHARMERAL
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
HYDROCHLOROTHIAZIDE W/ RESERPINE | HYDROCHLOROTHIAZIDE; RESERPINE | 25MG;0.125MG | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
03/17/1977 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
01/22/1982 | SUPPL-22 | Manufacturing (CMC) |
Label is not available on this site. |
||
01/22/1982 | SUPPL-21 | Manufacturing (CMC) |
Label is not available on this site. |